From the Editor-in-Chief's Desk: Reflecting on Our Past and Future

Ayvaci ER , Minhajuddin A , Elmore JS , et al. Treatment of adolescent depression: Comparison of psychiatric and pediatric settings at an academic medical center using the VitalSign⁶ application. J Child Adolesc Psychopharmacol, 2024; 34(2):80–88; doi: 10.1089/cap.2023.0041

Kanu AA , Johnston MM , Poweleit EA , et al. Influence of CYP2D6 metabolizer status on risperidone and paliperidone tolerability in children and adolescents. J Child Adolesc Psychopharmacol, 2024; 34(1):34–41; doi: 10.1089/cap.2023.0046

Lineham A , Avila-Quintero VJ , Bloch MH , Dwyer J . Exploring predictors of ketamine response in adolescent treatment-resistant depression. J Child Adolesc Psychopharmacol, 2024; 34(2):73–79; doi: 10.1089/cap.2023.0047

Malik S , Verma P , Ruaño G , et al. Pharmacogenetics in child and adolescent psychiatry: Background and evidence-based clinical applications. J Child Adolesc Psychopharmacol, 2024; 34(1):4–20; doi: 10.1089/cap.2023.0074

Nooraeen S , Croarkin PE , Geske JR , High probability of gene-drug interactions associated with medication side effects in adolescent depression: Results from a randomized controlled trial of pharmacogenetic testing. J Child Adolesc Psychopharmacol, 2024; 34(1):28–33; doi: 10.1089/cap.2023.0043

Powers JH , Wu M , Palumbo M , et al. Guanfacine for the treatment of ADHD in children and adolescents with Down syndrome: A retrospective chart review. J Child Adolesc Psychopharmacol, 2024; 34(2):95–103; doi: 10.1089/cap.2023.0069

Thom RP , Canales C , Tresvalles M , et al. Neuroimaging research in William's syndrome: Beginning to bridge the gap with clinical care. Neurosci Biobehav Rev, 2023; 153:105364; doi: 10.1016/j.neubiorev.2023.105364

Thomas R , Sellers A , Fierstein JL , et al. Suicide, stimulants, and selective serotonin reuptake inhibitors:A Retrospective Chart Review. J Child Adolesc Psychopharmacol, 2024; 34(2):89–94; doi: 10.1089/cap.2023.0068

Weinschutz Mendes H , Neelakantan U , Liu Y , et al. High-throughput functional analysis of autism genes in zebrafish identifies convergence in dopaminergic and neuroimmune pathways. Cell Rep, 202328;42(3):112243; doi: 10.1016/j.celrep.2023.112243